Yu Jeffrey, Chief Medical Officer of OneMedNet Corp, has made a notable stock acquisition, purchasing 45,126 shares of the company. This transaction, reported in a recent SEC filing, reflects Jeffrey's confidence in the company's prospects and its ongoing growth strategy.
OneMedNet Corp operates in the commercial physical and biological research sector. The company is incorporated in Delaware and has a fiscal year ending on December 31. The recent filing indicates that Yu Jeffrey has become a significant stakeholder in the firm, now owning a total of 896,840 shares following this transaction.
The filing, dated October 13, 2026, reveals that the shares were acquired at a price of $5.54 each, based on the volume-weighted average price for the ten trading days leading up to the purchase. The acquisition was part of a subscription agreement for a total investment of $250,000, which underscores the commitment of Jeffrey to the company's future.
According to the filing, the shares are held in trust for Jeffrey's children, with an independent trustee managing the investment. Jeffrey disclaims beneficial ownership of these shares for the purposes of Section 16 and other regulations, indicating a careful approach to compliance and governance.
This acquisition may influence other executives and stakeholders in the commercial physical and biological research industry, as it signals a strong belief in OneMedNet's potential. As the market evolves, competitors may need to assess their own strategies in light of such significant insider transactions.
Details were not available in the SEC filing regarding any future actions or plans following this transaction.